Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Third-generation Mineralocorticoid Receptor Antagonists
Elise P. Gómez-Sánchez
Journal of Cardiovascular Pharmacology (2015) Vol. 67, Iss. 1, pp. 26-38
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

The renin–angiotensin system in cardiovascular autonomic control: recent developments and clinical implications
Amanda J. Miller, Amy C. Arnold
Clinical Autonomic Research (2018) Vol. 29, Iss. 2, pp. 231-243
Open Access | Times Cited: 251
30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development
Peter Kolkhof, Lars Bärfacker
Journal of Endocrinology (2017) Vol. 234, Iss. 1, pp. T125-T140
Open Access | Times Cited: 218
Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA)
Pantelis Sarafidis, Fotini Iatridi, Charles J. Ferro, et al.
Clinical Kidney Journal (2023) Vol. 16, Iss. 11, pp. 1885-1907
Open Access | Times Cited: 26
Biochemical Mechanisms and Translational Relevance of Hippocampal Vulnerability to Distant Focal Brain Injury: The Price of Stress Response
N. V. Gulyaeva
Biochemistry (Moscow) (2019) Vol. 84, Iss. 11, pp. 1306-1328
Closed Access | Times Cited: 70
Aldosterone-induced oxidative stress and inflammation in the brain are mediated by the endothelial cell mineralocorticoid receptor
Quynh Nhu Dinh, Morag J. Young, Megan A. Evans, et al.
Brain Research (2016) Vol. 1637, pp. 146-153
Closed Access | Times Cited: 66
Immunomodulation and immunopharmacology in heart failure
George Markousis‐Mavrogenis, Lukas Baumhove, Ali A. Al‐Mubarak, et al.
Nature Reviews Cardiology (2023) Vol. 21, Iss. 2, pp. 119-149
Closed Access | Times Cited: 22
Mineralocorticoid Receptor-Associated Mechanisms in Diabetic Kidney Disease and Clinical Significance of Mineralocorticoid Receptor Antagonists
Christian W. Mende, Rohan Samarakoon, Paul J. Higgins
American Journal of Nephrology (2023) Vol. 54, Iss. 1-2, pp. 50-61
Open Access | Times Cited: 17
Preclinical pharmacology of AZD9977: A novel mineralocorticoid receptor modulator separating organ protection from effects on electrolyte excretion
Krister Bamberg, Ulrika Johansson, K. A. P. Edman, et al.
PLoS ONE (2018) Vol. 13, Iss. 2, pp. e0193380-e0193380
Open Access | Times Cited: 59
Antihypertensive effects and safety of esaxerenone in patients with moderate kidney dysfunction
Sadayoshi Ito, Hiroshi Itoh, Hiromi Rakugi, et al.
Hypertension Research (2020) Vol. 44, Iss. 5, pp. 489-497
Open Access | Times Cited: 48
Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism
Xiao Lin, Muhammad Hasnain Ehsan Ullah, Wu Xiong, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 26
Mineralocorticoid antagonists in chronic kidney disease
Omar Al Dhaybi, George L. Bakris
Current Opinion in Nephrology & Hypertension (2016) Vol. 26, Iss. 1, pp. 50-55
Closed Access | Times Cited: 40
Epidermal Mineralocorticoid Receptor Plays Beneficial and Adverse Effects in Skin and Mediates Glucocorticoid Responses
Julia Boix, Lisa M. Sevilla, Zara Sáez, et al.
Journal of Investigative Dermatology (2016) Vol. 136, Iss. 12, pp. 2417-2426
Open Access | Times Cited: 32
C9orf72 ALS/FTD dipeptide repeat protein levels are reduced by small molecules that inhibit PKA or enhance protein degradation
Nausicaa Valentina Licata, Riccardo Cristofani, Sally Salomonsson, et al.
The EMBO Journal (2021) Vol. 41, Iss. 1
Open Access | Times Cited: 27
Corticosteroid‐regulated gene transcription in SH‐SY5Y‐derived neurons: Insights into the mineralocorticoid and glucocorticoid receptor‐mediated response
Justina F. Lugenbühl, Clara Snijders, Cameron D. Pernia, et al.
Journal of Neuroendocrinology (2025)
Closed Access
Chinese Guidelines for the Prevention and Treatment of Hypertension (2024 revision)
Ji‐Guang Wang
Journal of Geriatric Cardiology (2025) Vol. 22, Iss. 1, pp. 1-149
Closed Access
Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
Nina Hojs, Sebastjan Bevc, Robert Ekart, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 6, pp. 561-561
Open Access | Times Cited: 21
Approaches towards tissue‐selective pharmacology of the mineralocorticoid receptor
Dorien Clarisse, Lisa Deng, Karolien De Bosscher, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 13, pp. 3235-3249
Open Access | Times Cited: 21
Modulating Mineralocorticoid Receptor with Non-steroidal Antagonists. New Opportunities for the Development of Potent and Selective Ligands without Off-Target Side Effects
Mercedes Martín‐Martínez, Felipe L. Pérez-Gordillo, Diego Álvarez de la Rosa, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 7, pp. 2629-2650
Closed Access | Times Cited: 25
Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
Kuo‐How Huang, Chih‐Chin Yu, Ya‐Hui Hu, et al.
Journal of the Formosan Medical Association (2018) Vol. 118, Iss. 1, pp. 72-82
Open Access | Times Cited: 24
Steroid hormone secretion after stimulation of mineralocorticoid and NMDA receptors and cardiovascular risk in patients with depression
Jan Nowacki, Katja Wingenfeld, Michael Kaczmarczyk, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 23
Interleukin 6 mediated activation of the mineralocorticoid receptor in the aldosterone-sensitive distal nephron
Brandi M. Wynne, Trinity K. Samson, Hayley Catherine Moyer, et al.
AJP Cell Physiology (2022) Vol. 323, Iss. 5, pp. C1512-C1523
Open Access | Times Cited: 14
Novel Approaches in Chronic Renal Failure without Renal Replacement Therapy: A Review
Sandra Luz Martínez-Hernández, Martín Humberto Muñoz‐Ortega, Manuel Enrique Ávila‐Blanco, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2828-2828
Open Access | Times Cited: 7
Taming resistant hypertension: The promise of novel pharmacologic approaches and renal denervation
Omar Azzam, Sayeh Heidari Nejad, Revathy Carnagarin, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 3, pp. 319-339
Open Access | Times Cited: 6
The selective mineralocorticoid receptor modulator AZD9977 reveals differences in mineralocorticoid effects of aldosterone and fludrocortisone
Krister Bamberg, Lena William‐Olsson, Ulrika Johansson, et al.
Journal of the Renin-Angiotensin-Aldosterone System (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 13
Role of Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
Maria Eleni Alexandrou, Marieta Theodorakopoulou, Pantelis Sarafidis
Kidney and Dialysis (2022) Vol. 2, Iss. 2, pp. 163-182
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top